Devinder Singh Rawat

His days at the prestigious Indian Institute of Technology (Bombay) pursuing Masters in Biotechnology kindled fascination for chemical compounds and biological molecules. Subsequently his stint as Research Fellow at the All India Institute of Medical Sciences and the sensitive Defence Research and Development Organization exposed him to the world of patenting and its importance.

With a graduation in Chemistry and a post-graduate degree in Biotechnology, Devinder has drafted over 75 patents in diverse fields including chemicals, pharmaceuticals, healthcare and medical devices, for various jurisdiction including the United States, the United Kingdom, Australia, Singapore and India.

He delivers end to end patent strategy and services to his clients. He is heavily involved in patent prosecution and patent analytics including patentability and freedom to operate searches and opinions. Swift patent approval translates into clients getting a better value proposition through monetization during the stipulated 20 year patent lifespan. That’s the biggest bonanza clients get when they knock on the doors of Anand and Anand he believes.

He is also regularly involved in complex pharmaceutical and life sciences contentious patent matters. His plate of pre-grant in the chosen domain is full, although post-grant activities equally engage him. He has been involved in several pre-grant and post-grant oppositions before the Indian Patent Office involving several new chemical entities. He has been instrumental in providing keen insights and critical review of the subject matter of cases before various judicial and quasi-judicial forums in India, such as the High Court. He regularly appears before the Intellectual Property Appellate Board.

He has co-authored the Indian chapter in Global Patent Litigation: How and Where to Win and the Indian Chapter dealing with ‘Organisation and financing of healthcare’ in Getting the Deal Through – Life Sciences 2019.

Prior to joining Anand and Anand he was a consultant for Eidogen-Sertanty Inc. and India HQ Solution for their drug discovery platform.